Digital Health is a very exciting space to build a business right now: the market is exponentially growing, reaching $14.6 billion in investments across the globe. So why hesitate? If you have a start-up, product or idea, now is the time to take it a step further with G4A 2019 Partnerships.
G4A is Bayer’s Digital Health team, identifying new technologies, business models and market trends rooted in behavioural science. This year, the Growth and Advance Tracks offer startups a gateway to partner with Bayer in the digital health space, no matter what stage you’re in. Applications are now open – but hurry, they close May 31st!
This unique opportunity will provide you with funding, chance for commercial partnerships, exclusive networking, access to Bayer experts, optional co-working space, executive mentoring and regional engagement.
For early stage startups
If your company is in the pre-product launch stage, the Growth Track is for you. G4A is looking for companies with a minimal viable product (MVP), and on-going validation or published findings for this track. Selected companies will receive a one-time initial funding (EUR 50,000 to EUR 100,000).
For mature companies
If you already have a product on the market and are looking for a strategic partner to propel your business, the Advance Trackis your way to go. Companies will be working jointly with Bayer experts to drive a commercial partnership co-funded by G4A. Successful companies will receive funding (EUR 50,000 to EUR 100,000) and additional payments when jointly defined milestones are reached.
Since G4A’s launch in 2013, Bayer has supported over ~150 digital health companies. This has resulted in ~30 direct collaborations with companies such as Turbine, Quid and Agamon. Bayer now operates G4A in more than 13 countries, developing and promoting collaborative health care projects around the world.
“Working with G4A has shaved months off of our “go to market” timeline. It has been instrumental in providing valuable guidance and exposure to specialists, relevant information in all of the appropriate technical and business areas necessary for getting a medical products company started.” says Joe Curcio, CEO, Kinaptic about their experience.
“The program is tailor-made for digital health companies, taking you from validating your idea, connecting you to the right stakeholders within the organization, and providing you the essential tools to build your product all the way to commercialization and partnerships.” Michal Meiri, Co-Founder & CEO, Agamon adds.
How to apply?
If you are passionate about changing the experience of health with your product or service and you are over 18 or a legal entity, you’re good to go. Gather all the info about your company and team, create a video or attach your pitch deck and apply here by 31 May.
G4A is looking for digital health solutions in the following challenge areas: Cardiovascular, Dermatology, Digital Therapeutics, Global Health, Neuro-technology, Oncology, Ophthalmology, Pulmonology, Radiology, Voice Tech, Women’s Health.
Don’t worry, you don’t have to fit your idea into one category – you can choose up to 3 challenges during submission.
After the application period closes, Bayer and G4A Experts will select the finalists. In August, shortlisted companies will be invited to workshops with Bayer and G4A to determine if there is a mutually beneficial fit. In early October, finalists are headed to Berlin to sign and get started!